PubMed Health⌕ Search

PubMed · 11151813

[HIV, AIDS and ethics].

Abstract

The epidemic spread of HIV infections and the AIDS disease in the last two decades of the 20th century has quite unexpectedly confronted European civilization, including North America, with a great number of ethical problems. Today, two decades after the first signs of AIDS' possibly epidemic threat not only to individual regions but to the entire population of the world, we can already answer the questions whether Western society has learned from the past and whether the concern for the rights of the individual and of groups previously discriminated in one way or another (a concern increasing since the 1950 s initially in the USA and then in Europe) has led to a more sensitive stance in dealing with victims of the HIV and AIDS epidemic. In Europe and North America, after initial unrest and occasionally exaggerated reactions, the confrontation with HIV infection and AIDS has mostly shown a marked improvement over the way epidemics and their victims were dealt with in earlier centuries. A substantial difference from earlier epidemics is that the understandable temptation to identify the disease with a specific group of persons has meanwhile been overcome; instead of collectively discriminating against people whose style of life substantially contributes to the spread of the disease, the focus of investigation is on behaviors; increasingly, the actors are not mentioned. There is probably no other disease that touches upon a comparably broad spectrum of ethical principles. HIV infection and the AIDS disease provide models for evaluating almost all basic ethical principles that can find application in a medical context. From the identification of those infected, the search for an effective therapy, the treatment of the diseased, to the compassion with the dying and in many other respects a historically unprecedented degree of taking into regard the interests of groups at risk and of those affected have been taken into account. It is in view of the global dimension of the HIV/AIDS epidemic that a second challenge confronts European civilisation. Here the formulation of relevant politics has not been (and is unlikely to be) influenced by emotions or an abstract morale. Rather, it has been a recognition of a self-interest of Western nations vis-a-vis a possible scenario of a breakdown of public order and democratic structures in some parts of the world that has brought about a reorientation. Increasingly, the resources of governments, of science, and of private enterprise of Western nations are brought together to match the needs of those non-Western countries where the HIV/AIDS epidemic has reached catastrophic dimensions. It may well be that these efforts will support the development of vaccines and therapies affordable in these countries.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P U Unschuld. 2000. [HIV, AIDS and ethics].. https://doi.org/10.1007/s001010070028

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Regression analysis of failure time data with informative interval censoring.

Interval censoring arises when a subject misses prescheduled visits at which the failure is to be assessed. Most existing approaches for analysing interval-censored failure time data assume that the censoring mechanism is independent of the true failure time. However, there are situations where this assumption may not hold. In this paper, we consider such a situation in which the dependence structure between the censoring variables and the failure time can be modelled through some latent variables and a method for regression analysis of failure time data is proposed. The method makes use of the proportional hazards frailty model and an EM algorithm is presented for estimation. Finite sample properties of the proposed estimators of regression parameters are examined through simulation studies and we illustrate the method with data from an AIDS study.

Acquired Immunodeficiency Syndrome↗

Two and a half years of routine HIV testing in Botswana.

BACKGROUND: Botswana was the first African country to introduce routine HIV testing (RHT). OBJECTIVE: To report program data for the first 2.5 years of RHT. METHODS: RHT was introduced in 2004. Rapid HIV tests were introduced later the same year and are widely available. The main criteria for RHT are symptoms of HIV/AIDS, pregnancy, sexually transmitted infection, and attendance for medical examination. Testing may also be self-initiated. FINDINGS: There has been a rapid scale-up of RHT. A total of 60,846 persons were tested through RHT in 2004 versus 157,894 in 2005 and 88,218 in the first half of 2006. Testing rates in the population through RHT were 40 per 1000 persons, 93 per 1000 persons, and 104 per 1000 persons, respectively. In 2005, 89% of those offered testing accepted, with 69% of those tested being female and 31% male. The proportion of men who tested HIV-positive was 34% versus 30% for women. The main reasons for testing in 2005 were patient's wish (50%), pregnancy (25%), medical examination (7%), clinical suspicion (6%), and sexually transmitted infection (2%). Attendance at voluntary counseling and testing centers has increased parallel to the scale-up of RHT. CONCLUSIONS: RHT has been widely accepted by the population, and no adverse effects or instances have been reported. It has provided increased access to preventive services and earlier assessment for antiretroviral treatment. We believe the benefits of RHT clearly outweigh the risks.

Acquired Immunodeficiency Syndrome↗

Risk factors for human Herpesvirus 8 infection and AIDS-associated Kaposi's sarcoma among men who have sex with men in a European multicentre study.

We aimed to identify risk factors for Kaposi's sarcoma (KS) among HIV-positive patients and behaviors associated with human Herpesvirus 8 (HHV-8) infection, as well as to assess KS incidence and mortality rates longitudinally. To fulfill the first objective, a European case-control study was designed in the early 1990s (each KS case was matched to 2 controls with another AIDS indicative disease). After the discovery of HHV-8, serology testing enabled us to assess risk factors for KS development among HHV-8 and HIV-1 coinfected men who have sex with men (MSM), as well as risk factors for HHV-8 infection. HHV-8 seroprevalence was determined using a latent immunofluorescence assay. Relevant information was obtained by means of a questionnaire and medical charts review. Assessment of risk factors for KS development and HHV-8 infection was performed using conditional and unconditional logistic regression models, respectively. A low CD4 count was the only significant risk factor for KS. HHV-8 infection was most strongly linked to the number of life-time sex partners, and multiple body fluids such as saliva and semen are quite likely involved in sexual transmission. Longitudinal follow up showed a significant protective role for highly-active antiretroviral therapy (HAART) both on KS development and mortality of KS patients. Although more conclusive data from cohort studies are needed to better define specific transmission mechanisms for HHV-8, our results contribute to explain why KS incidence is higher among MSM, and the decreasing KS incidence trend observed in countries with universal access to HAART.

Acquired Immunodeficiency Syndrome↗